New Delhi [India], March 6 (ANI/SRV): Aaquaries Global Industries Limited, a research-based integrated pharmaceutical company involved in niche API manufacturing & marketing of pharmaceutical ingredient supplier for foremost formulators with services, including APIs, custom pharmaceutical services, generics, biosimilars, and differentiated formulations with leadership position in Anti Malarial APIs, Anti Cancer APIs, Veterinary APIs has made an announcement today that Aaquaries Global Industries Limited will be investing about USD 200 Million in buyout of assets and patents and has raised money for the long term investments.
